A detailed history of Armistice Capital, LLC transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 6,893,410 shares of ALGS stock, worth $3.24 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,893,410
Previous 6,833,875 0.87%
Holding current value
$3.24 Million
Previous $4.51 Million 49.78%
% of portfolio
0.09%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.64 - $1.13 $38,102 - $67,274
59,535 Added 0.87%
6,893,410 $6.76 Million
Q4 2023

Feb 13, 2024

BUY
$0.56 - $0.8 $3.83 Million - $5.47 Million
6,833,875 New
6,833,875 $4.51 Million

Others Institutions Holding ALGS

About Aligos Therapeutics, Inc.


  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $18.7M
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.